Cargando…

Prevalence and triggers of self-reported nasal hyperreactivity in adults with asthma

BACKGROUND: Nasal hyperreactivity (NHR) is a common feature of various rhinitis subtypes and represents a novel phenotype of rhinitis. It is being reported in two-thirds of adult rhinitis patients irrespective of the atopic status. Data on the prevalence of NHR in patients with asthma are lacking, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feijen, Jef, Seys, Sven F., Steelant, Brecht, Bullens, Dominique M.A., Dupont, Lieven J., García-Cruz, Maria, Jimenez-Chobillón, Alejandro, Larenas-Linnemann, Désirée, Van Gerven, Laura, Fokkens, Wytske J., Agache, Ioana, Hellings, Peter W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334478/ https://www.ncbi.nlm.nih.gov/pubmed/32642023 http://dx.doi.org/10.1016/j.waojou.2020.100132

Ejemplares similares

Innate Lymphoid Cells Are Required to Induce Airway Hyperreactivity in a Murine Neutrophilic Asthma Model
por: Jonckheere, Anne-Charlotte, et al.
Publicado: (2022)

Corrigendum: Innate lymphoid cells are required to induce airway hyperreactivity in a murine neutrophilic asthma model
por: Jonckheere, Anne-Charlotte, et al.
Publicado: (2022)

Endotype-driven treatment in chronic upper airway diseases
por: De Greve, Glynnis, et al.
Publicado: (2017)

Visual analogue scale for sino-nasal symptoms severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burden
por: Doulaptsi, Maria, et al.
Publicado: (2018)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
por: Doulaptsi, Maria, et al.
Publicado: (2021)

Epithelial barriers in allergy and asthma
por: Hellings, Peter W., et al.
Publicado: (2020)

Calu-3 epithelial cells exhibit different immune and epithelial barrier responses from freshly isolated primary nasal epithelial cells in vitro
por: Martens, Katleen, et al.
Publicado: (2018)

Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management
por: Bachert, C., et al.
Publicado: (2018)

Taste Receptors: The Gatekeepers of the Airway Epithelium
por: Martens, Katleen, et al.
Publicado: (2021)

A TRiP Through the Roles of Transient Receptor Potential Cation Channels in Type 2 Upper Airway Inflammation
por: Backaert, Wout, et al.
Publicado: (2021)

Th2-high asthma: a heterogeneous asthma population?
por: Sven, Seys, et al.
Publicado: (2015)

Lacticaseibacillus casei AMBR2 Restores Airway Epithelial Integrity in Chronic Rhinosinusitis With Nasal Polyps
por: Martens, Katleen, et al.
Publicado: (2021)

IL-17A in Human Respiratory Diseases: Innate or Adaptive Immunity? Clinical Implications
por: Bullens, Dominique M. A., et al.
Publicado: (2013)

Erratum: Lacticaseibacillus casei AMBR2 Restores Airway Epithelial Integrity in Chronic Rhinosinusitis With Nasal Polyps
por: Martens, Katleen, et al.
Publicado: (2021)

Sputum “IL-5, IL-17A, IL-25-high” pattern is associated with uncontrolled asthma and worse lung function
por: Seys, Sven, et al.
Publicado: (2013)

Nasal hyperreactivity and inflammation in allergic rhinitis
por: Garrelds, I. M., et al.
Publicado: (1996)

Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients
por: Seys, Sven F., et al.
Publicado: (2017)

A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
por: Fokkens, Wytske, et al.
Publicado: (2015)

Brain activation after nasal histamine provocation in house dust mite allergic rhinitis patients
por: Callebaut, Ina, et al.
Publicado: (2020)

Chronic rhinosinusitis with nasal polyps in the elderly
por: Cornet, Marjolein, et al.
Publicado: (2013)

A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
por: Hellings, Peter, et al.
Publicado: (2015)

Precision Medicine in Chronic Rhinosinusitis with Nasal Polyps
por: Avdeeva, Klementina, et al.
Publicado: (2018)

O02 - Exercise-induced bronchoconstriction in young athletes
por: Seys, Sven, et al.
Publicado: (2014)

A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity
por: Scadding, Glenis, et al.
Publicado: (2013)

Actual therapeutic management of allergic and hyperreactive nasal disorders
por: Rudack, Claudia
Publicado: (2004)

Capsaicin for Rhinitis
por: Fokkens, Wytske, et al.
Publicado: (2016)

A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
por: Hellings, Peter, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion
por: Bachert, Claus, et al.
Publicado: (2013)

Management of Intractable Nasal Hyperreactivity by Selective Resection of Posterior Nasal Nerve Branches
por: Takahara, Daisuke, et al.
Publicado: (2017)

Association between outdoor air pollution and chronic rhinosinusitis patient reported outcomes
por: Peeters, S., et al.
Publicado: (2022)

Diagnostic strategies in nasal congestion
por: Krouse, John, et al.
Publicado: (2010)

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
por: Van Broeck, Dorien, et al.
Publicado: (2023)

Symptoms of chronic rhinosinusitis with and without nasal polyps
por: Dietz de Loos, Dirk, et al.
Publicado: (2013)

The Impact of Allergic Rhinitis and Asthma on Human Nasal and Bronchial Epithelial Gene Expression
por: Wagener, Ariane H., et al.
Publicado: (2013)

Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013)

IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?
por: Bullens, Dominique MA, et al.
Publicado: (2006)

ARIA México 2014: transculturization of a guideline involving 11 national medical societies
por: Larenas-Linnemann, Désirée
Publicado: (2015)

How does the efficacy and safety of Oralair(®) compare to other products on the market?
por: Larenas-Linnemann, Désirée
Publicado: (2016)

Identification of gaps in the current allergic rhinitis guidelines and how these can be filled
por: Bousquet, Jean, et al.
Publicado: (2015)

How an online survey on the treatment of allergic rhinitis and its impact on asthma (ARIA) detected specialty-specific knowledge-gaps
por: Larenas Linnemann, Désirée ES, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8dhj3sq1ma3ms8lkvemfs0n206